We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Photoacoustic Technology May Revolutionize Cancer Research

By LabMedica International staff writers
Posted on 13 Apr 2011
Innovative technology that combines the sensitivity of optical imaging with the resolution and depth penetration of high-frequency ultrasound will enable researchers to study cancer in its earliest stages of progression and evaluate tumor growth and the effect that potential drugs have on that growth.

The VisualSonics Inc. More...
(Toronto, Canada) Vevo LAZR uses a laser to shoot pulses of light through the skin into tissue and cells beneath the surface. The absorbed laser energy is then converted into heat, producing an ultrasonic emission, which can be captured and turned into images using a specially adapted high frequency ultrasonic probe. VisualSonics is a wholly owned subsidiary of SonoSite Inc. (Seattle, WA, USA).

The key to this novel approach is the capability of a wide range of biological materials to absorb laser light. Specific tissue components including oxyhemoglobin, deoxyhemoglobin, melanin, and lipids all absorb laser energy, which is then converted into heat that produces an ultrasonic emission that can be captured and turned into images using a specially adapted high frequency ultrasonic probe.

Applications for the Vevo LAZR system range from lymph node imaging to the study of hemoglobin and oxygen saturation and the targeted imaging of tumor biomarkers. In addition to cancer biology, this innovative technology will benefit other areas of life science research such as diabetes, neurosciences, and developmental and reproductive biology.

"The Vevo LAZR photoacoustics system is a breakthrough in vivo imaging technology,” said Anil Amlani president and CEO of VisualSonics. "Advancements featured in this product will enable oncology researchers to accelerate their research into understanding of the inner workings of the cancerous cell and the host tissue in which it resides. The ability to conduct this microscopic level research in a living organism, noninvasively and in real time will help our customers to turn groundbreaking science into lifesaving care, at an even greater speed.”

"We believe that the Vevo LAZR system will have a strong impact on the discovery of new cancer therapies, more efficient testing of therapies with never-before-seen insights into cancer, and quantified measures of cancer progression, viewed from inside the tumor,” said Kevin M. Goodwin, president and CEO of SonoSite. "With the launch of Vevo LAZR technology, we continue to meet our commitment to our customers by providing imaging technologies needed to further tomorrow's research today.”

Related Links:

VisualSonics Inc.
SonoSite Inc.



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.